There's still time to REGISTER to attend the #HCWGlobalInvestment2022 conference in-person at the Fontainebleau Hotel in #MiamiBeach May 23-26. Join us for keynote speakers, presenting companies, investor one-on-one meetings and networking opportunities:

We are initiating coverage on @AcumenPharm ($ABOS) a clinical-stage company developing a novel disease-modifying approach to Alzheimer's disease. Details in the #HCWCO Morning Summary; #BiopharmaInvestors

We are initiating coverage on @NRxPharma ($NRXP) which is focused on therapies for central nervous system disorders and life-threatening respiratory diseases. More in the #HCWCO Morning Summary; #PharmaInvestors

We are initiating coverage on @theseusrx ($THRX) which is focused on developing pan-inhibition treatments for gastrointestinal stromal tumors. Read more in the #HCWCO Morning Summary; #HealthcareInvestors

Save the date! #HCWCO Private Company Showcase Aug 2-4, 2022 In-Person Conference! Learn more:

Catch up on the #HCWCO #psychedelics podcast by accessing the #HCWCOMediaRoom here:

Our #investmentbanking team continues to execute transactions. Learn more by clicking here: #HCWCO

Join our team of industry and #financialprofessionals. Learn more about a career at #HCWCO here: #investmentbank

Save the date and register! #HCWCO 2nd Annual Ophthalmology Virtual Conference is around the corner. August 17, 2022. Learn more here:

Our #corporateaccess team hosts #institutionalinvestor events throughout the year. See our recent and upcoming events here:

Update on #InflaRx ($IFRX): According to the FDA website, Vilobelimab has been granted Orphan Drug Designation for the treatment of pyoderma gangrenosum. More in the #HCWCO Morning Summary; #HealthcareInvestors

Headquartered in #NewYorkCity & servicing a global client base. Our #HCWCO team has a keen sense of trends across all potential market landscapes:

Tomorrow join us for the #HCWCO Preclinical Cancer Drug Discovery: Emerging Targets and Modalities – Virtual Conference. Click the link to register and learn more!

The #HCWCO #EquityResearch team covers 640+ public companies in Life Sciences & #Healthcare, Metals & Mining, #CleanTech, Technology, Financial Technology & #Cryptocurrency. See our coverage here:

Today is the day. #HCWCO 1st Annual #MentalHealth Conference: Neuropsychiatry, Psychedelics, and Beyond. Click the link to join virtually:

Tomorrow, don't miss the 1st Annual #HCWCO Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond. Click here to register: #psychedelicsinvestors #investors

You couldn't attend? Don't worry, visit the #HCWCO Media Room. Find #investorpresentations along with recordings of #KOL events and our Weekly #PsychedelicsPodcast here:

#HCWCO is a #capitalmarkets, analysis-driven, full service #investmentbank. Our expert #investmentbanking team facilitates a diverse range of transactions. Learn more about our capabilities:

June 29th, join us at the #HCWCO Preclinical Cancer Drug Discovery: Emerging Targets and Modalities. #institutionalinvestor

The #HCWCO equity research team delivers insights on a wide range of #CleanTech, Alternative Energy, and Environmental Solutions companies. Review our Clean Tech coverage universe here: #ESGinvestors #institutionalinvestors

#Angioedema is swelling underneath the skin. Join #HCWCO at the 1st Annual Hereditary Angioedema (HAE) Virtual Conference on July 20, 2022. Click here to register: